Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trial
Publication in refereed journal

Times Cited
Altmetrics Information

Other information
AbstractAim We examined the effects of adding glargine to metformin-sitagliptin (MS + G) or sitagliptin to metformin-glargine (MG + S) therapy in type 2 diabetic persons uncontrolled after 24-week MS or MG dual therapy.
All Author(s) ListChan J.C.N., Aschner P., Owens D.R., Picard S., Vincent M., Dain M.-P., Pilorget V., Loizeau V., Echtay A., Fonseca V.
Journal nameJournal of Diabetes and its Complications
Volume Number29
Issue Number1
PublisherElsevier BV
Place of PublicationNetherlands
Pages134 - 141
LanguagesEnglish-United Kingdom
KeywordsEASIE A1c, Insulin glargine, Metformin, Sitagliptin, Type 2 diabetes

Last updated on 2020-25-11 at 03:19